vs
STANDARD BIOTOOLS INC.（LAB）与百捷租车（SMRT）财务数据对比。点击上方公司名可切换其他公司
百捷租车的季度营收约是STANDARD BIOTOOLS INC.的1.9倍（$36.5M vs $19.6M），百捷租车净利率更高（-8.9% vs -177.4%，领先168.5%），百捷租车同比增速更快（3.1% vs -11.5%），百捷租车自由现金流更多（$7.7M vs $-23.1M），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -15.0%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
百捷租车是美国知名汽车租赁企业，1958年由莫里斯·米尔金创立于加州洛杉矶，如今是安飞士百捷集团旗下子品牌，运营总部设在新泽西州帕西帕尼，在全球汽车租赁市场拥有广泛的业务布局与品牌影响力。
LAB vs SMRT — 直观对比
营收规模更大
SMRT
是对方的1.9倍
$19.6M
营收增速更快
SMRT
高出14.6%
-11.5%
净利率更高
SMRT
高出168.5%
-177.4%
自由现金流更多
SMRT
多$30.7M
$-23.1M
两年增速更快
LAB
近两年复合增速
-15.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $36.5M |
| 净利润 | $-34.7M | $-3.2M |
| 毛利率 | 48.5% | 38.6% |
| 营业利润率 | -168.5% | -10.9% |
| 净利率 | -177.4% | -8.9% |
| 营收同比 | -11.5% | 3.1% |
| 净利润同比 | -28.8% | 71.6% |
| 每股收益（稀释后） | $-0.09 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABSMRT
| Q4 25 | — | $36.5M | ||
| Q3 25 | $19.6M | $36.2M | ||
| Q2 25 | $21.8M | $38.3M | ||
| Q1 25 | $40.8M | $41.3M | ||
| Q4 24 | — | $35.4M | ||
| Q3 24 | $22.1M | $40.5M | ||
| Q2 24 | $22.5M | $48.5M | ||
| Q1 24 | $45.5M | $50.5M |
净利润LABSMRT
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $-34.7M | $-6.3M | ||
| Q2 25 | $-33.5M | $-10.9M | ||
| Q1 25 | $-26.0M | $-40.2M | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | $-26.9M | $-9.9M | ||
| Q2 24 | $-45.7M | $-4.6M | ||
| Q1 24 | $-32.2M | $-7.7M |
毛利率LABSMRT
| Q4 25 | — | 38.6% | ||
| Q3 25 | 48.5% | 26.4% | ||
| Q2 25 | 48.8% | 33.1% | ||
| Q1 25 | 48.4% | 32.8% | ||
| Q4 24 | — | 28.7% | ||
| Q3 24 | 54.9% | 33.2% | ||
| Q2 24 | 46.1% | 35.7% | ||
| Q1 24 | 53.1% | 38.5% |
营业利润率LABSMRT
| Q4 25 | — | -10.9% | ||
| Q3 25 | -168.5% | -19.4% | ||
| Q2 25 | -118.1% | -30.5% | ||
| Q1 25 | -80.8% | -99.9% | ||
| Q4 24 | — | -36.6% | ||
| Q3 24 | -120.9% | -29.0% | ||
| Q2 24 | -134.5% | -14.3% | ||
| Q1 24 | -132.2% | -20.1% |
净利率LABSMRT
| Q4 25 | — | -8.9% | ||
| Q3 25 | -177.4% | -17.3% | ||
| Q2 25 | -153.7% | -28.3% | ||
| Q1 25 | -63.8% | -97.2% | ||
| Q4 24 | — | -32.3% | ||
| Q3 24 | -122.0% | -24.5% | ||
| Q2 24 | -203.3% | -9.5% | ||
| Q1 24 | -70.6% | -15.2% |
每股收益（稀释后）LABSMRT
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.09 | $-0.03 | ||
| Q2 25 | $-0.09 | $-0.06 | ||
| Q1 25 | $-0.07 | $-0.21 | ||
| Q4 24 | — | $-0.06 | ||
| Q3 24 | $-0.07 | $-0.05 | ||
| Q2 24 | $-0.12 | $-0.02 | ||
| Q1 24 | $-0.27 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $104.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $232.1M |
| 总资产 | $539.6M | $320.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABSMRT
| Q4 25 | — | $104.5M | ||
| Q3 25 | $129.4M | $100.0M | ||
| Q2 25 | $158.6M | $105.0M | ||
| Q1 25 | $150.9M | $125.6M | ||
| Q4 24 | — | $142.5M | ||
| Q3 24 | $210.6M | $163.4M | ||
| Q2 24 | $269.8M | $187.4M | ||
| Q1 24 | $287.1M | $204.7M |
总债务LABSMRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABSMRT
| Q4 25 | — | $232.1M | ||
| Q3 25 | $399.7M | $234.4M | ||
| Q2 25 | $424.5M | $238.8M | ||
| Q1 25 | $454.6M | $250.7M | ||
| Q4 24 | — | $289.4M | ||
| Q3 24 | $489.3M | $305.1M | ||
| Q2 24 | $510.3M | $329.4M | ||
| Q1 24 | $577.3M | $333.1M |
总资产LABSMRT
| Q4 25 | — | $320.9M | ||
| Q3 25 | $539.6M | $335.8M | ||
| Q2 25 | $557.0M | $354.0M | ||
| Q1 25 | $579.6M | $366.1M | ||
| Q4 24 | — | $420.2M | ||
| Q3 24 | $681.5M | $448.6M | ||
| Q2 24 | $708.7M | $475.3M | ||
| Q1 24 | $777.7M | $485.5M |
负债/权益比LABSMRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $7.7M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $7.7M |
| 自由现金流率自由现金流/营收 | -118.1% | 21.0% |
| 资本支出强度资本支出/营收 | 4.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-25.1M |
8季度趋势，按日历期对齐
经营现金流LABSMRT
| Q4 25 | — | $7.7M | ||
| Q3 25 | $-22.2M | $-2.1M | ||
| Q2 25 | $-20.7M | $-14.9M | ||
| Q1 25 | $-30.3M | $-12.2M | ||
| Q4 24 | — | $-12.0M | ||
| Q3 24 | $-27.9M | $-3.7M | ||
| Q2 24 | $-39.0M | $-13.9M | ||
| Q1 24 | $-62.5M | $-3.3M |
自由现金流LABSMRT
| Q4 25 | — | $7.7M | ||
| Q3 25 | $-23.1M | $-2.2M | ||
| Q2 25 | $-22.6M | $-16.2M | ||
| Q1 25 | $-35.3M | $-14.3M | ||
| Q4 24 | — | $-13.3M | ||
| Q3 24 | $-30.1M | $-3.9M | ||
| Q2 24 | $-41.0M | $-14.1M | ||
| Q1 24 | $-63.3M | $-3.4M |
自由现金流率LABSMRT
| Q4 25 | — | 21.0% | ||
| Q3 25 | -118.1% | -6.1% | ||
| Q2 25 | -103.6% | -42.3% | ||
| Q1 25 | -86.6% | -34.7% | ||
| Q4 24 | — | -37.5% | ||
| Q3 24 | -136.4% | -9.7% | ||
| Q2 24 | -182.2% | -29.1% | ||
| Q1 24 | -138.9% | -6.7% |
资本支出强度LABSMRT
| Q4 25 | — | 0.0% | ||
| Q3 25 | 4.5% | 0.2% | ||
| Q2 25 | 8.7% | 3.3% | ||
| Q1 25 | 12.4% | 5.3% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 10.2% | 0.6% | ||
| Q2 24 | 8.6% | 0.5% | ||
| Q1 24 | 1.7% | 0.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
SMRT
| Hosted Services | $18.1M | 50% |
| Hardware Service | $12.5M | 34% |
| Smart Operations Solutions | $2.6M | 7% |
| Access Control | $2.0M | 5% |
| Other Smart Communities Solutions | $1.3M | 3% |
